Pancreatic Cancer Research

ResearcherVrije Universiteit BrusselNo recent work listed

Mark J. Cowley

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9519-5714; OpenAlex author ID A5076066174. Sources: OpenAlex.

Their work

Papers
17
Trials
0
Grants
0
Labs led
0
Collaborators
64
Papers, trials and grants by year

2012: 2 papers · 2013: 3 papers · 2014: 2 papers · 2015: 2 papers · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper

Papers 17

  1. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2020.09.043↗
  2. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2020.107625↗
  3. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003143↗
  4. Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2017-315144↗
  5. SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer. Co-author DOI 10.1038/onc.2017.63↗
  6. Hypermutation In Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2016.09.060↗
  7. Mitochondrial mutations and metabolic adaptation in pancreatic cancer. Co-author DOI 10.1186/s40170-017-0164-1↗
  8. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  9. Whole genomes redefine the mutational landscape of pancreatic cancer. Co-author DOI 10.1038/nature14169↗
  10. SOX9 regulates ERBB signalling in pancreatic cancer development. Co-author DOI 10.1136/gutjnl-2014-307075↗
  11. Clinical and pathologic features of familial pancreatic cancer. Co-author DOI 10.1002/cncr.28863↗
  12. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Co-author DOI 10.1002/ijc.28765↗
  13. Understanding pancreatic cancer genomes. Co-author DOI 10.1007/s00534-013-0610-6↗
  14. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-12-3359↗
  15. Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Co-author DOI 10.1186/gm482↗
  16. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Co-author DOI 10.1038/nature11547↗
  17. RON is not a prognostic marker for resectable pancreatic cancer. Co-author DOI 10.1186/1471-2407-12-395↗

Closest collaborators

The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew Victor Biankin · 11 shared papers, 2012–2020 · strength 0.46
  2. Marina Pajic · 9 shared papers, 2013–2020 · strength 0.40
  3. Sean Michael Grimmond · 8 shared papers, 2012–2018 · strength 0.30
  4. David Kuang-Fu Chang · 7 shared papers, 2012–2020 · strength 0.28
  5. Amber L. Johns · 6 shared papers, 2013–2020 · strength 0.25
  6. Anthony James Gill · 6 shared papers, 2012–2020 · strength 0.24
  7. Jaswinder Singh Samra · 4 shared papers, 2013–2020 · strength 0.18
  8. Venessa T. Chin · 4 shared papers, 2013–2020 · strength 0.18
  9. Lorraine A. Chantrill · 4 shared papers, 2013–2020 · strength 0.18
  10. Adnan M. Nagrial · 4 shared papers, 2013–2020 · strength 0.18
  11. Angela S. Y. Chou · 4 shared papers, 2012–2020 · strength 0.18
  12. Jeremy L. Humphris · 3 shared papers, 2013–2020 · strength 0.13
  13. Ilse Rooman · 4 shared papers, 2013–2015 · strength 0.12
  14. Claire Vennin · 2 shared papers, 2017–2018 · strength 0.11
  15. Jennifer P. Morton · 2 shared papers, 2017–2018 · strength 0.11
  16. Paul Timpson · 2 shared papers, 2017–2018 · strength 0.11
  17. Darren N. Saunders · 2 shared papers, 2017 · strength 0.11
  18. James G. Kench · 2 shared papers, 2014–2020 · strength 0.10
  19. Emily K. Colvin · 2 shared papers, 2013–2020 · strength 0.10
  20. Peter J. Bailey · 2 shared papers, 2014–2020 · strength 0.10
  21. Kátia Nones · 3 shared papers, 2012–2014 · strength 0.08
  22. Stephan B. Dreyer · 1 shared paper, 2020 · strength 0.07
  23. Nam Quoc Nguyen · 1 shared paper, 2020 · strength 0.07
  24. Thomas Knösel · 1 shared paper, 2020 · strength 0.07
  25. Christopher James Scarlett · 1 shared paper, 2020 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.